PharmaEssentia Statistics

Total Valuation

PharmaEssentia has a market cap or net worth of TWD 189.07 billion. The enterprise value is 169.26 billion.

Market Cap	189.07B
Enterprise Value	169.26B

Important Dates

The last earnings date was Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

PharmaEssentia has 332.29 million shares outstanding. The number of shares has increased by 6.10% in one year.

Current Share Class	n/a
Shares Outstanding	332.29M
Shares Change (YoY)	+6.10%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	8.78%
Owned by Institutions (%)	10.61%
Float	255.72M

Valuation Ratios

The trailing PE ratio is 102.68 and the forward PE ratio is 34.38.

PE Ratio	102.68
Forward PE	34.38
PS Ratio	22.62
PB Ratio	7.25
P/TBV Ratio	7.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 120.09, with an EV/FCF ratio of 386.96.

EV / Earnings	91.70
EV / Sales	20.34
EV / EBITDA	120.09
EV / EBIT	159.30
EV / FCF	386.96

Financial Position

The company has a current ratio of 12.31, with a Debt / Equity ratio of 0.04.

Current Ratio	12.31
Quick Ratio	11.53
Debt / Equity	0.04
Debt / EBITDA	0.73
Debt / FCF	2.34
Interest Coverage	46.32

Financial Efficiency

Return on equity (ROE) is 7.39% and return on invested capital (ROIC) is 2.57%.

Return on Equity (ROE)	7.39%
Return on Assets (ROA)	2.37%
Return on Capital (ROIC)	2.57%
Revenue Per Employee	63.51M
Profits Per Employee	14.09M
Employee Count	131
Asset Turnover	0.30
Inventory Turnover	0.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+59.38%
50-Day Moving Average	639.06
200-Day Moving Average	502.08
Relative Strength Index (RSI)	33.38
Average Volume (20 Days)	1,284,369

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEssentia had revenue of TWD 8.32 billion and earned 1.85 billion in profits. Earnings per share was 5.54.

Revenue	8.32B
Gross Profit	7.25B
Operating Income	1.06B
Pretax Income	1.93B
Net Income	1.85B
EBITDA	1.17B
EBIT	1.06B
Earnings Per Share (EPS)	5.54

Full Income Statement

Balance Sheet

The company has 20.83 billion in cash and 1.02 billion in debt, giving a net cash position of 19.81 billion or 59.62 per share.

Cash & Cash Equivalents	20.83B
Total Debt	1.02B
Net Cash	19.81B
Net Cash Per Share	59.62
Equity (Book Value)	26.08B
Book Value Per Share	78.50
Working Capital	22.69B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.54 billion and capital expenditures -1.10 billion, giving a free cash flow of 437.42 million.

Operating Cash Flow	1.54B
Capital Expenditures	-1.10B
Free Cash Flow	437.42M
FCF Per Share	1.32

Full Cash Flow Statement

Margins

Gross margin is 87.10%, with operating and profit margins of 12.77% and 22.19%.

Gross Margin	87.10%
Operating Margin	12.77%
Pretax Margin	23.17%
Profit Margin	22.19%
EBITDA Margin	14.08%
EBIT Margin	12.77%
FCF Margin	5.26%

Dividends & Yields

PharmaEssentia does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.10%
Shareholder Yield	-6.10%
Earnings Yield	0.97%
FCF Yield	0.23%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaEssentia has an Altman Z-Score of 29.42.

Altman Z-Score	29.42
Piotroski F-Score	n/a